Functional screen of inflammatory bowel disease genes reveals key epithelial functions.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
11 11 2021
Historique:
received: 12 07 2021
accepted: 21 10 2021
entrez: 11 11 2021
pubmed: 12 11 2021
medline: 22 2 2022
Statut: epublish

Résumé

Genetic studies have been tremendously successful in identifying genomic regions associated with a wide variety of phenotypes, although the success of these studies in identifying causal genes, their variants, and their functional impacts has been more limited. We identified 145 genes from IBD-associated genomic loci having endogenous expression within the intestinal epithelial cell compartment. We evaluated the impact of lentiviral transfer of the open reading frame (ORF) of these IBD genes into the HT-29 intestinal epithelial cell line via transcriptomic analyses. By comparing the genes in which expression was modulated by each ORF, as well as the functions enriched within these gene lists, we identified ORFs with shared impacts and their putative disease-relevant biological functions. Analysis of the transcriptomic data for cell lines expressing the ORFs for known causal genes such as HNF4a, IFIH1, and SMAD3 identified functions consistent with what is already known for these genes. These analyses also identified two major clusters of genes: Cluster 1 contained the known IBD causal genes IFIH1, SBNO2, NFKB1, and NOD2, as well as genes from other IBD loci (ZFP36L1, IRF1, GIGYF1, OTUD3, AIRE and PITX1), whereas Cluster 2 contained the known causal gene KSR1 and implicated DUSP16 from another IBD locus. Our analyses highlight how multiple IBD gene candidates can impact on epithelial structure and function, including the protection of the mucosa from intestinal microbiota, and demonstrate that DUSP16 acts a regulator of MAPK activity and contributes to mucosal defense, in part via its regulation of the polymeric immunoglobulin receptor, involved in the protection of the intestinal mucosa from enteric microbiota. This functional screen, based on expressing IBD genes within an appropriate cellular context, in this instance intestinal epithelial cells, resulted in changes to the cell's transcriptome that are relevant to their endogenous biological function(s). This not only helped in identifying likely causal genes within genetic loci but also provided insight into their biological functions. Furthermore, this work has highlighted the central role of intestinal epithelial cells in IBD pathophysiology, providing a scientific rationale for a drug development strategy that targets epithelial functions in addition to the current therapies targeting immune functions.

Sections du résumé

BACKGROUND
Genetic studies have been tremendously successful in identifying genomic regions associated with a wide variety of phenotypes, although the success of these studies in identifying causal genes, their variants, and their functional impacts has been more limited.
METHODS
We identified 145 genes from IBD-associated genomic loci having endogenous expression within the intestinal epithelial cell compartment. We evaluated the impact of lentiviral transfer of the open reading frame (ORF) of these IBD genes into the HT-29 intestinal epithelial cell line via transcriptomic analyses. By comparing the genes in which expression was modulated by each ORF, as well as the functions enriched within these gene lists, we identified ORFs with shared impacts and their putative disease-relevant biological functions.
RESULTS
Analysis of the transcriptomic data for cell lines expressing the ORFs for known causal genes such as HNF4a, IFIH1, and SMAD3 identified functions consistent with what is already known for these genes. These analyses also identified two major clusters of genes: Cluster 1 contained the known IBD causal genes IFIH1, SBNO2, NFKB1, and NOD2, as well as genes from other IBD loci (ZFP36L1, IRF1, GIGYF1, OTUD3, AIRE and PITX1), whereas Cluster 2 contained the known causal gene KSR1 and implicated DUSP16 from another IBD locus. Our analyses highlight how multiple IBD gene candidates can impact on epithelial structure and function, including the protection of the mucosa from intestinal microbiota, and demonstrate that DUSP16 acts a regulator of MAPK activity and contributes to mucosal defense, in part via its regulation of the polymeric immunoglobulin receptor, involved in the protection of the intestinal mucosa from enteric microbiota.
CONCLUSIONS
This functional screen, based on expressing IBD genes within an appropriate cellular context, in this instance intestinal epithelial cells, resulted in changes to the cell's transcriptome that are relevant to their endogenous biological function(s). This not only helped in identifying likely causal genes within genetic loci but also provided insight into their biological functions. Furthermore, this work has highlighted the central role of intestinal epithelial cells in IBD pathophysiology, providing a scientific rationale for a drug development strategy that targets epithelial functions in addition to the current therapies targeting immune functions.

Identifiants

pubmed: 34758847
doi: 10.1186/s13073-021-00996-7
pii: 10.1186/s13073-021-00996-7
pmc: PMC8582123
doi:

Substances chimiques

Butyrate Response Factor 1 0
Carrier Proteins 0
GIGYF1 protein, human 0
IRF1 protein, human 0
Immunoglobulins 0
Interferon Regulatory Factor-1 0
Paired Box Transcription Factors 0
Transcription Factors 0
ZFP36L1 protein, human 0
homeobox protein PITX1 0
Protein Kinases EC 2.7.-
KSR-1 protein kinase EC 2.7.1.-
Mitogen-Activated Protein Kinase Phosphatases EC 3.1.3.16
DUSP16 protein, human EC 3.1.3.48
Dual-Specificity Phosphatases EC 3.1.3.48
OTUD3 protein, human EC 3.4.19.12
Ubiquitin-Specific Proteases EC 3.4.19.12

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

181

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK062432
Pays : United States

Investigateurs

Alain Bitton (A)
Gabrielle Boucher (G)
Guy Charron (G)
Christine Des Rosiers (CD)
Anik Forest (A)
Philippe Goyette (P)
Sabine Ivison (S)
Lawrence Joseph (L)
Rita Kohen (R)
Jean Lachaine (J)
Sylvie Lesage (S)
Megan K Levings (MK)
John D Rioux (JD)
Julie Thompson Legault (JT)
Luc Vachon (L)
Sophie Veilleux (S)
Brian White-Guay (B)

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2017 Jul 13;547(7662):173-178
pubmed: 28658209
Ciba Found Symp. 1983;95:34-49
pubmed: 6342998
World J Gastroenterol. 2014 Jan 7;20(1):22-30
pubmed: 24415854
Clin Cancer Res. 2011 May 1;17(9):2619-27
pubmed: 21372217
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Virology. 1973 Apr;52(2):456-67
pubmed: 4705382
Front Immunol. 2019 Apr 10;10:647
pubmed: 31024529
Immunol Invest. 2010;39(4-5):356-82
pubmed: 20450283
Trends Microbiol. 2019 Jan;27(1):75-85
pubmed: 30201512
Nat Genet. 2017 Feb;49(2):186-192
pubmed: 28067910
Nat Commun. 2016 Aug 09;7:12342
pubmed: 27503255
J Biol Chem. 2001 Oct 19;276(42):39002-11
pubmed: 11489891
Nature. 2006 Jul 6;442(7098):39-44
pubmed: 16823444
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
Nat Immunol. 2016 Mar;17(3):241-9
pubmed: 26692175
Nature. 2020 Jan;577(7789):254-259
pubmed: 31853059
Nature. 2001 May 31;411(6837):603-6
pubmed: 11385577
PLoS Genet. 2013;9(9):e1003723
pubmed: 24068945
Nat Rev Microbiol. 2010 Sep;8(9):656-67
pubmed: 20694027
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):693-8
pubmed: 24385580
Nat Genet. 2011 Oct 09;43(11):1066-73
pubmed: 21983784
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W193-200
pubmed: 17478515
Biochim Biophys Acta. 2009 Feb;1793(2):281-9
pubmed: 18952129
Immunity. 2015 Oct 20;43(4):715-26
pubmed: 26488816
Cell Mol Gastroenterol Hepatol. 2019;7(3):555-570
pubmed: 30553809
J Immunol. 2007 Dec 1;179(11):7215-9
pubmed: 18025162
Nat Commun. 2018 Apr 24;9(1):1612
pubmed: 29691392
Nat Genet. 2007 Feb;39(2):207-11
pubmed: 17200669
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
Bioinformatics. 2008 Dec 15;24(24):2938-9
pubmed: 18974171
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Genome Res. 2003 May;13(5):773-80
pubmed: 12727897
Nat Rev Rheumatol. 2020 Apr;16(4):222-237
pubmed: 32107482
J Biol Chem. 2001 Jul 13;276(28):26629-39
pubmed: 11359773
J Med Genet. 2013 May;50(5):324-9
pubmed: 23423984
J Immunol. 2010 Nov 1;185(9):5577-85
pubmed: 20921534
Viruses. 2018 May 03;10(5):
pubmed: 29751532
J Clin Invest. 2001 Aug;108(4):523-6
pubmed: 11518725
Nature. 2001 May 31;411(6837):599-603
pubmed: 11385576
J Virol. 2008 Dec;82(23):11526-35
pubmed: 18829757
Nature. 2020 Jan;577(7789):260-265
pubmed: 31853061
Immunol Cell Biol. 2012 May;90(5):483-91
pubmed: 22410872
J Immunol. 1999 Feb 1;162(3):1232-5
pubmed: 9973374
Eur J Pharm Sci. 2004 Jan;21(1):25-51
pubmed: 14706810
J Clin Invest. 2019 Jul 22;129(8):2983-2993
pubmed: 31329162
BMC Bioinformatics. 2005 Sep 14;6:227
pubmed: 16162296
Nat Genet. 2007 May;39(5):596-604
pubmed: 17435756
Front Physiol. 2019 Dec 12;10:1484
pubmed: 31871440
Science. 2018 Mar 9;359(6380):1161-1166
pubmed: 29420262
FEBS J. 2016 May;283(10):1812-22
pubmed: 26663363
Drug Metab Pharmacokinet. 2008;23(1):2-7
pubmed: 18305369
Gut. 2009 Aug;58(8):1121-7
pubmed: 19398441
Bioinformatics. 2007 Aug 15;23(16):2183-4
pubmed: 17586828
Gastroenterology. 2003 Jul;125(1):47-57
pubmed: 12851870
BMC Genomics. 2008 Aug 08;9:377
pubmed: 18691394
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
J Virol. 2002 Nov;76(21):10972-9
pubmed: 12368340
Nat Genet. 2008 Sep;40(9):1107-12
pubmed: 19165925
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
J Mol Biol. 2019 Jun 14;431(13):2398-2406
pubmed: 31100387
Curr Opin Microbiol. 2002 Feb;5(1):76-80
pubmed: 11834373
Cell Physiol Biochem. 2018;51(1):173-185
pubmed: 30439714
Biochem Soc Trans. 2013 Aug;41(4):1078-82
pubmed: 23863182
Mucosal Immunol. 2011 Jul;4(4):468-78
pubmed: 21451502
J Biol Chem. 2016 Apr 15;291(16):8673-85
pubmed: 26887945
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321258
Cell. 2018 Oct 4;175(2):598-599
pubmed: 30290144
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Cell. 2016 Apr 21;165(3):551-65
pubmed: 27040498
J Clin Invest. 2005 Mar;115(3):695-702
pubmed: 15765149
World J Gastroenterol. 2006 Mar 21;12(11):1657-70
pubmed: 16586532
Nature. 2011 Jun 15;474(7351):307-17
pubmed: 21677747
Nat Genet. 2009 Dec;41(12):1330-4
pubmed: 19915572
BMC Immunol. 2019 May 2;20(1):13
pubmed: 31046669
Genes Dev. 2007 Apr 1;21(7):756-69
pubmed: 17403778
Science. 2006 Dec 1;314(5804):1461-3
pubmed: 17068223
Nat Commun. 2018 Jun 21;9(1):2427
pubmed: 29930244
Annu Rev Pathol. 2016 May 23;11:127-48
pubmed: 26907531
Nat Genet. 2015 Feb;47(2):172-9
pubmed: 25559196
Gut. 2014 Dec;63(12):1921-31
pubmed: 24555997
Nat Cell Biol. 2015 Sep;17(9):1169-81
pubmed: 26280536
Science. 2016 Apr 22;352(6284):453-9
pubmed: 27102483

Auteurs

Jessy Carol Ntunzwenimana (JC)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.
Université de Montréal, Montreal, Quebec, Canada.

Gabrielle Boucher (G)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Jean Paquette (J)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Hugues Gosselin (H)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Azadeh Alikashani (A)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Nicolas Morin (N)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Claudine Beauchamp (C)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Louise Thauvette (L)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Marie-Ève Rivard (MÈ)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Frédérique Dupuis (F)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Sonia Deschênes (S)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Sylvain Foisy (S)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Frédéric Latour (F)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Geneviève Lavallée (G)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Mark J Daly (MJ)

Massachusetts General Hospital, Boston, MA, USA.
The Broad Institute, Cambridge, MA, USA.

Ramnik J Xavier (RJ)

Massachusetts General Hospital, Boston, MA, USA.
The Broad Institute, Cambridge, MA, USA.

Guy Charron (G)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

Philippe Goyette (P)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada.

John D Rioux (JD)

Montreal Heart Institute Research Centre, 5000 rue Bélanger, S-6201, Montreal, Quebec, Canada. John.david.rioux@umontreal.ca.
Université de Montréal, Montreal, Quebec, Canada. John.david.rioux@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH